A Phase I Study of Lapatinib and Cetuximab in Patients With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2015
At a glance
- Drugs Cetuximab (Primary) ; Lapatinib (Primary)
- Indications Colorectal cancer; Head and neck cancer; Non-small cell lung cancer
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2013 Planned End Date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.